Pharmaceutical Commerce - March 2020
Dramatic growth tracks the flood of new specialty pharmaceuticals entering the market
ICER will expand use of RWE, as the Federal ONC calls for broader use of healthcare data
Clarivate Analytics predicts both approvals and commercial potential
A former executive at PhRMA, Davis will now lead the wholesaler-distributor association
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
How Specialty Growth and Cold Chain Demand Are Rewriting Distribution Strategy
2
Why Geopolitical Supply Chain Mapping Is Critical for Life Sciences
3
Commercial Trade's Expanding Mandate: From Product Movement to Commercial Performance
4
Mid-Year Check-In: Has Prior Auth Reform Delivered?
5